Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Blood pressure control in diabetes—the Indian perspective

Abstract

A tremendous increase in the coexistence of diabetes and hypertension has been observed recently in India. Apart from lifestyle and genetic factors, socioeconomic status, age, gender, occupation and lack of awareness are also contributing to the tremendous increases in the prevalence of both the diseases. Hypertension has been long recognised as one of the major risk factors for chronic disease burden, morbidity and mortality in India, attributable to 10.8% of all deaths in the country. Even though microvascular complications are frequently linked to hyperglycaemia, studies have also proven the critical involvement of hypertension in the development of these co-morbidities. The co-occurrence of hypertension in diabetic patients considerably escalates the risks of coronary heart disease, stroke, nephropathy and retinopathy. The annual expenditure for diabetes for the Indian population was estimated to be 1541.4 billion INR ($31.9 billion) in 2010. The expense of diabetes care further escalates in the presence of complications or co-morbidities. Generally, a diabetic patient with hypertension spent an average of 1.4 times extra than a diabetic patient without hypertension. Even though diabetes and hypertension are considered as important risk factors for cardiovascular and chronic kidney diseases, the awareness about the prevention, treatment and control of these diseases remains alarmingly low in the developing countries like India. The healthcare system in India should focus on better hypertension screening and control, especially in diabetic patients, to minimise the burden of the dual epidemic.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. The official website for International Diabetes Foundation––South-East Asia. https://www.idf.org/our-network/regions-members/south-east-asia/members/94-india.html. Accessed 28 Feb 2019.

  2. The atlas of heart disease and stroke. World Health Organization. https://www.who.int/cardiovascular_diseases/resources/atlas/en/.

  3. Noncommunicable diseases country profiles 2018. World Health Organization. https://www.who.int/nmh/publications/ncd-profiles-2018/en/.

  4. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Angelantonioa ED, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32:1–8.

    Google Scholar 

  5. Sahay BK. API-ICP guidelines on diabetes 2007. J Assoc Physicians India. 2007;55:1–50.

    Google Scholar 

  6. Hypertension in Diabetic Study (HDS) . Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens. 1993;11:309–17.

    Google Scholar 

  7. Williams G. Hypertension in diabetes. In: Pickup J, Williams G, (eds). Textbook of diabetes. London: Blackwell Scientific Publications; 1991. p. 719–32.

    Google Scholar 

  8. Parving HH, Andersen AR, Smidt UM, Oxenboll B, Edsberg B, Christiansen JS. Diabetic nephropathy and arterial hypertension. Diabetologia. 1983;24:10–12.

    CAS  PubMed  Google Scholar 

  9. Joshi SR, Saboo B, Vadivale M, Dani SI, Mithal A, Kaul U, et al. Prevalence of diagnosed and undiagnosed diabetes and hypertension in India—results from the Screening India’s Twin Epidemic (SITE) study. Diabetes Technol Ther. 2012;14:8–15. 14 (1)

    PubMed  Google Scholar 

  10. Gupta R, Gaur K, Ram CVS. Emerging trends in hypertension epidemiology in India. J Hum Hypertens. 2018. https://doi.org/10.1038/s41371-018-0117-3.

    PubMed  Google Scholar 

  11. Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5:585–96.

    PubMed  Google Scholar 

  12. Gupta R, Al-Odat NA, Gupta VP. Hypertension epidemiology in India: meta-analysis of fifty-year prevalence rates and blood pressure trends. J Hum Hypertens. 1996;10:465–72.

    CAS  PubMed  Google Scholar 

  13. Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004;18:73–78.

    CAS  PubMed  Google Scholar 

  14. Thankappan KR, Sivasankaran S, Sarma PS, Mini G, Khader SA, Padmanabhan P, et al. Prevalence-correlates-awareness-treatment and control of hypertension in Kumarakom, Kerala: baseline results of a community-based intervention program. Indian Heart J. 2006;58:28–33.

    CAS  PubMed  Google Scholar 

  15. Gupta R. Meta-analysis of prevalence of hypertension in India. Indian Heart J. 1997;49:450.

    PubMed  Google Scholar 

  16. Das SK, Sanyal K, Basu A. Study of urban community survey in India: growing trend of high prevalence of hypertension in a developing country. Int J Med Sci. 2005;2:70–78.

    PubMed  PubMed Central  Google Scholar 

  17. Singh PS, Singh PK, Zafar KS, Sharma H, Yadav SK, Gautam RK, et al. Prevalence of hypertension in rural population of Central India. Int J Res Med Sci. 2017;5:1451–5.

    Google Scholar 

  18. Gupta R, Gupta VP. Hypertension epidemiology in India: lessons from Jaipur Heart Watch. Curr Sci. 2009;97:349–55.

    Google Scholar 

  19. NCD-RisC. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55.

    Google Scholar 

  20. Shanthirani CS, Pradeepa R, Deepa R, Premlatha G, Saroja R, Mohan V. Prevalence and risk factors of hypertension in a selected South Indian population. The Chennai Urban Population Study. J Assoc Physicians India. 2003;51:20–27.

    CAS  PubMed  Google Scholar 

  21. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

    PubMed  Google Scholar 

  22. Taing KY, Farkouh ME, Moineddin R, Tu JV, Jha P. Age and sex-specific associations of anthropometric measures of adiposity with blood pressure and hypertension in India: a cross-sectional study. BMC Cardiovasc Disord. 2016;16:247.

    PubMed  PubMed Central  Google Scholar 

  23. Page RM, Stones E, Taylor O, Braudt K. Awareness and perceptions of type 2 diabetes risk factors, preventability, and complications among college students in Visakhapatnam, India. Int Q Community Health Educ. 2016;37:27–32.

    PubMed  Google Scholar 

  24. Long AN, Dagogo-Jack S. The comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens. 2011;13:244–51.

    Google Scholar 

  25. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–92.

    PubMed  Google Scholar 

  26. Yamazaki D, Hitomi H, Nishiyama A. Hypertension with diabetes mellitus complications. Hypertens Res. 2018;41:147–56.

    PubMed  Google Scholar 

  27. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.

    PubMed  PubMed Central  Google Scholar 

  28. Sowers JR. Treatment of hypertension in patients with diabetes. Arch Intern Med. 2004;164:1850–7.

    CAS  PubMed  Google Scholar 

  29. El-Atat F, McFarlane SI, Sowers JR. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep. 2004;6:215–23.

    PubMed  Google Scholar 

  30. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37:1053–9.

    CAS  PubMed  Google Scholar 

  31. Govindarajan G, Sowers JR, Stump CS. Hypertension and diabetes mellitus. Eur Cardiovasc Dis. 2006;2:1–7.

    Google Scholar 

  32. Bakris G, Williams M, Dworkin L, Elliott W, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. J Kidney Dis. 2000;36:646.

    CAS  Google Scholar 

  33. Sowers JR, Haffner S. Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. Hypertension. 2002;40:781–8.

    CAS  PubMed  Google Scholar 

  34. Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res. 2012;136:46–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India. Ann Glob Health. 2016;82:307–15.

    PubMed  Google Scholar 

  36. Registrar General of India. Causes of deaths in India, 2001–2003. New Delhi, India: Office of the Registrar General; 2009.

    Google Scholar 

  37. Registrar General of India. Sample Registration System Report. New Delhi, India: Office of the Registrar General. 2011 www.censusindia.gov.in/2011-common/sample_registration_system.html. Accessed 27 Jan 2016.

  38. Institute for HealthMetrics and Evaluation (IHME) Global burden of disease (GBD) database. Seattle, WA: IHME, University of Washington; 20145. P. http://www.healthdata.org/gbd/data. Accessed 17 Jul 2015.

  39. Rodgers A, Lawes C, MacMahon S. Reducing the global burden of blood pressure related cardiovascular disease. J Hypertens. 2000;18(Suppl 1):S3–S6.

    CAS  Google Scholar 

  40. Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Tharkar S, Devarajan A, Kumpatla S, Viswanathan V. The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diabetes Res Clin Pract. 2010;89:334–40.

    PubMed  Google Scholar 

  42. Bhaskaran VP, Rau NR, Satyashankar, Acharya RR, Metgud CS, Koshy T. A study of the direct cost incurred by type 2 diabetes mellitus patients for their treatment at a large tertiary-care hospital in Karnataka, India. J Acad Hosp Adm. 2003;15:7–12.

    Google Scholar 

  43. Satyavani K, Kothandan H, Jayaraman M, Viswanathan V. Direct costs associated with chronic kidney disease among type 2 diabetic patients in India. Indian J Nephrol. 2014;24:141–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Khanna U. The economics of dialysis in India. Indian J Nephrol. 2009;19:1–4.

    PubMed  PubMed Central  Google Scholar 

  45. Adler AJ, Prabhakaran D, Bovet P, Kazi DS, Mancia G, Mungat-Singh V, et al. Reducing cardiovascular mortality through prevention and management of raised blood pressure. Glob Heart. 2015;10:111–22.

    PubMed  Google Scholar 

  46. Angell S, De Cock KM, Frieden TR. A public health approach to global management of hypertension. Lancet. 2015;385:825–7.

    PubMed  PubMed Central  Google Scholar 

  47. Gupta R, Khedar RS, Panwar RB. Strategies for better hypertension control in India and other lower middle income countries. J Assoc Physicians India. 2016;64:58–64.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vijay Viswanathan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Viswanathan, V., Smina, T.P. Blood pressure control in diabetes—the Indian perspective. J Hum Hypertens 33, 588–593 (2019). https://doi.org/10.1038/s41371-019-0212-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-019-0212-0

This article is cited by

Search

Quick links